Determining the appropriate retatrutide dosage is critically necessary for obtaining optimal results . Initially, patients typically commence with a modest dose of around 2.4 mg, administered once week via subcutaneous . This starting quantity is then incrementally increased every four weeks , until a maximum quantity of 10.8 mg, based on individu